N-3 fatty acids and chylomicron metabolism in the rat. 1997

W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
Department of Medicine, University of Kansas Medical Center, Kansas City 66160, USA.

Dietary n-3 fatty acids (FAs) reduce postprandial triacylglycerol concentrations in humans by unknown mechanisms. Our goals were to reproduce this phenomenon in the rat, and then to determine the mechanism. In an oral fat tolerance study two groups of rats were fed diets containing 2.1% ethyl esters of n-3 FA or olive oil for 2 weeks. After gavaging with emulsified soybean oil, the postprandial chylomicron triacylglycerol levels in the n-3 FA group were reduced by 40% (P < 0.05). The hypothesis that n-3 FA feeding reduced chylomicron production/secretion from the gut was tested by blocking chylomicron removal with Triton WR1339 before gavaging the rats with the fat load. This completely eliminated the hypochylomicronemic effect suggesting that chylomicron input was not inhibited by n-3 FAs. Chylomicron clearance was studied by injecting chylomicrons containing radioactive retinyl esters and triacylglycerol into rats from both groups. Pre-feeding with n-3 FAs accelerated the removal of chylomicron triacylglycerol and retinyl esters from the plasma with significantly lower fractions of dose remaining at 2, 4, and 8 min post-injection for both tracers. These findings suggest than n-3 FAs reduce postprandial chylomicronemia in the rat by accelerating chylomicron lipid clearance.

UI MeSH Term Description Entries
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002914 Chylomicrons A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS. Chylomicron

Related Publications

W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
January 2001, World review of nutrition and dietetics,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
January 1994, World review of nutrition and dietetics,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
February 1971, Biochimica et biophysica acta,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
November 1968, The Journal of physiology,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
July 1991, Lipids,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
October 1965, Annals of the New York Academy of Sciences,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
January 1989, Journal of internal medicine. Supplement,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
December 2001, Biochimica et biophysica acta,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
July 2000, Biochimica et biophysica acta,
W S Harris, and B E Hustvedt, and E Hagen, and M H Green, and G Lu, and C A Drevon
January 2009, Nutricion hospitalaria,
Copied contents to your clipboard!